The Goldman Sachs Group Reiterates “€87.50” Price Target for Fresenius Medical Care AG & Co. KGaA (FME.F) (ETR:FME)

Fresenius Medical Care AG & Co. KGaA (FME.F) (ETR:FME) received a €87.50 ($102.94) target price from stock analysts at The Goldman Sachs Group in a research note issued on Thursday, Borsen Zeitung reports. The brokerage presently has a “buy” rating on the stock. The Goldman Sachs Group’s target price would suggest a potential upside of 28.53% from the stock’s previous close.

Other equities research analysts have also recently issued research reports about the company. Sanford C. Bernstein set a €69.50 ($81.76) price target on Fresenius Medical Care AG & Co. KGaA (FME.F) and gave the company a “neutral” rating in a report on Thursday. Barclays set a €88.00 ($103.53) target price on Fresenius Medical Care AG & Co. KGaA (FME.F) and gave the stock a “buy” rating in a report on Wednesday, October 21st. JPMorgan Chase & Co. set a €94.80 ($111.53) target price on Fresenius Medical Care AG & Co. KGaA (FME.F) and gave the stock a “buy” rating in a report on Monday. Jefferies Financial Group set a €68.00 ($80.00) target price on Fresenius Medical Care AG & Co. KGaA (FME.F) and gave the stock a “neutral” rating in a report on Thursday. Finally, Deutsche Bank Aktiengesellschaft set a €100.00 ($117.65) target price on Fresenius Medical Care AG & Co. KGaA (FME.F) and gave the stock a “buy” rating in a report on Friday, July 31st. Six research analysts have rated the stock with a hold rating and ten have given a buy rating to the company’s stock. The stock has an average rating of “Buy” and an average price target of €83.29 ($97.99).

FME opened at €68.08 ($80.09) on Thursday. The business’s 50 day moving average is €71.37 and its 200-day moving average is €72.75. The stock has a market cap of $20.74 billion and a PE ratio of 15.53. The company has a current ratio of 1.02, a quick ratio of 0.68 and a debt-to-equity ratio of 101.16. Fresenius Medical Care AG & Co. KGaA has a twelve month low of €53.50 ($62.94) and a twelve month high of €81.10 ($95.41).

Fresenius Medical Care AG & Co. KGaA (FME.F) Company Profile

Fresenius Medical Care AG & Co KGaA, a kidney dialysis company, provides dialysis care and related services, and other health care services in Germany, the United States, and internationally. It offers dialysis treatment and related laboratory and diagnostic services through a network of outpatient dialysis clinics; materials, training, and patient support services comprising clinical monitoring, follow-up assistance, and arranging for delivery of the supplies to the patient's residence; and dialysis services under contract to hospitals in the United States for the hospitalized end-stage renal disease (ESRD) patients and for patients suffering from acute kidney failure.

Recommended Story: Put Option Volume

Analyst Recommendations for Fresenius Medical Care AG & Co. KGaA (FME.F) (ETR:FME)

Receive News & Ratings for Fresenius Medical Care AG & Co. KGaA (FME.F) Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Fresenius Medical Care AG & Co. KGaA (FME.F) and related companies with MarketBeat.com's FREE daily email newsletter.